tiprankstipranks
Trending News
More News >

Kerry Wentworth Insider Profile

4 Followers
Kerry Wentworth, VP, Clinical, Reg & Qual at Agenus, holds 50.00K shares in Nuvation Bio (Ticker: NUVB), holds 0.00 shares in Flexion Therapeutics (Ticker: ~FLXN), holds 57.41K shares in Agenus (Ticker: AGEN). Most recently, Kerry Wentworth Bought ― shares of Nuvation Bio on Jun 18, 2025 for an estimated value of 89.74K.
tipranks
Kerry Wentworth

Kerry Wentworth
Agenus (AGEN)
VP, Clinical, Reg & Qual

Not Ranked
Ranked #64,275 out of 102,596 Corporate Insiders
Kerry Wentworth has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$472K
73.43%
26.57%
A breakdown of Kerry Wentworth's holdings

Insider Roles

Agenus
(AGEN)
VP, Clinical, Reg & Qual
Nuvation Bio
(NUVB)
CHIEF REGULATORY OFFICER
Roles that Kerry Wentworth holds in companies

Most Profitable Insider Trade

Stock:
Nuvation Bio
(NUVB)
Rating:Informative Buy
Date:Jun 18, 2025 - Today
Return:+28.40%
The most profitable trade made by Kerry Wentworth

Kerry Wentworth's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Agenus
Feb 28, 2014
VP, Clinical, Reg & Qual
Uninformative Sell
25.00K
$346.76K
~FLXN
Flexion Therapeutics
Nov 19, 2021
Uninformative Sell
1.25M
$0.00
Nuvation Bio
Jun 18, 2025
CHIEF REGULATORY OFFICER
Informative Buy
89.74K
$125.50K
List of latest transactions for each holding click on a transaction to see Kerry Wentworth's performance on stock

Kerry Wentworth insider profile FAQ

What is the percentage of profitable transactions made by Kerry Wentworth?
The percentage of profitable transactions made by Kerry Wentworth is ―.
    What is the average return per transaction made by Kerry Wentworth?
    The average return per transaction made by Kerry Wentworth is ―.
      What stocks does Kerry Wentworth hold?
      Kerry Wentworth holds: AGEN, ~FLXN, NUVB stocks.
        What was Kerry Wentworth’s latest transaction?
        Kerry Wentworth latest transaction was an Informative Buy of $89.74K.
          What was Kerry Wentworth's most profitable transaction?
          Kerry Wentworth’s most profitable transaction was an Informative Buy of NUVB stock on June 18, 2025. The return on the trade was 28.40%.
            What is Kerry Wentworth's role in Agenus?
            Kerry Wentworth's role in Agenus is VP, Clinical, Reg & Qual.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.